Skip to content
10-Q

Quarterly Report

Dimension Therapeutics, Inc.

0001564590-16-028808

← back to feed
Filed
Nov 10, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 3, 2016 25.04M sh
Stockholders Equity Q3 2016 · Sep 30, 2016 $72.04M
Stockholders Equity Q3 2016 · Dec 31, 2015 $105.58M
Current Liabilities Q3 2016 · Sep 30, 2016 $18.13M
Current Liabilities Q3 2016 · Dec 31, 2015 $13.2M
Total Liabilities Q3 2016 · Sep 30, 2016 $35.14M
Total Liabilities Q3 2016 · Dec 31, 2015 $27.69M
Current Assets Q3 2016 · Sep 30, 2016 $98.46M
Current Assets Q3 2016 · Dec 31, 2015 $129.93M
Total Assets Q3 2016 · Sep 30, 2016 $107.18M
Total Assets Q3 2016 · Dec 31, 2015 $133.27M
Capex Q3 2016 · Sep 30, 2015 $2.19M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $69.25M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $17.91M
Sga Expense Q3 2016 · Sep 30, 2015 $2.33M
Sga Expense Q3 2016 · Sep 30, 2015 $6.12M
Rd Expense Q3 2016 · Sep 30, 2015 $10.37M
Rd Expense Q3 2016 · Sep 30, 2015 $25.24M
Net Income Q3 2016 · Sep 30, 2015 −$10.67M
Net Income Q3 2016 · Sep 30, 2015 −$26.03M
Operating Income Q3 2016 · Sep 30, 2015 −$10.65M
Operating Income Q3 2016 · Sep 30, 2015 −$25.96M
Revenue Q3 2016 · Sep 30, 2015 $2.06M
Revenue Q3 2016 · Sep 30, 2015 $5.4M